Gene Editing, Biotechnology, and Precision Medicine by Beam Therapeutics

  • Sholanke Dele
  • 04.06.2026
Beam Therapeutics stock edges higher 2.04% after award recognition, Beam Therapeutics notes
Beam Therapeutics received the 2026 Life Sciences Award from Triangle Business Journal, with the honor formally presented at the company's North Carolina office by a representative from Senator ...
  • Andreas Kristo
  • 06.11.2025
Beam Therapeutics achieves top CGT award for BEAM-302
Beam Therapeutics has been awarded the Overall CGT Solution of the Year for its alpha-1 antitrypsin deficiency program, BEAM-302. This recognition comes from the esteemed BioTech Awards, ...